Effect of Probiotic on Clinical Outcomes in Children with Pneumonia: A Randomized Double-Blind Trial
محل انتشار: مجله بین المللی کودکان، دوره: 14، شماره: 9
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 104
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_INJPM-14-9_001
تاریخ نمایه سازی: 7 آبان 1405
چکیده مقاله:
Background: Pneumonia remains a major cause of morbidity and mortality among children worldwide. Evidence suggests that probiotics may modulate immune responses and potentially improve respiratory infections. This study aimed to evaluate the effect of probiotic supplementation on clinical outcomes in children aged ۳ months to ۱۲ years hospitalized with pneumonia.Methods: In this double-blind randomized clinical trial, ۱۰۸ children diagnosed with pneumonia were allocated into two groups: ۵۴ received a daily ۱‑gram sachet of Protexin probiotic (containing ۱×۱۰⁹ CFU), and ۵۴ received a placebo matched in appearance. Clinical signs and symptoms, including fever, lethargy, tachypnea, cough, retraction, wheezing, rales, hypoxia, and length of hospital stay, were monitored at baseline and at scheduled follow-up intervals. Data analysis was performed using SPSS; t‑tests were applied for normally distributed quantitative variables and Mann–Whitney tests for non‑normal variables, with a significance level of P<۰.۰۵.Results: No significant differences were found between the probiotic and placebo groups regarding gender, age, baseline symptoms, or length of hospital stay (P>۰.۰۵ for all). However, the frequency of fever at ۳۶ and ۶۰ hours after admission was significantly lower in the probiotic group (P=۰.۰۳۷, P=۰.۰۳۴), and lethargy at ۳۶ hours after admission was significantly less common compared to the placebo group (P=۰.۰۰۹).Conclusions: While most clinical parameters did not differ between groups, probiotic supplementation was associated with a significant reduction in fever and lethargy during hospitalization. Probiotics may serve as a beneficial adjunct therapy in pediatric pneumonia, although further studies with larger sample sizes and detailed clinical endpoints are recommended.
کلیدواژه ها:
نویسندگان
- -
Department of Pediatrics, Ghaem Hospital, Mashhad University of Medical Science, Mashhad, Iran.
- -
Department of Pediatrics, Mashhad University of Medical Science, Mashhad, Iran.
- -
Department of Pediatrics, Mashhad University of Medical Science, Mashhad, Iran.
- -
Bojnord University of Medical Science, Bojnord, Iran.
- -
Bojnord University of Medical Science, Bojnord, Iran.
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :